相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term treatment with α-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome
Franca Fruzzetti et al.
GYNECOLOGICAL ENDOCRINOLOGY (2020)
Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study
Kamal Advani et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2020)
The insulin-sensitizing mechanism of myo-inositol is associated with AMPK activation and GLUT-4 expression in human endometrial cells exposed to a PCOS environment
Heidy Cabrera-Cruz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)
HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA)
Francesca Cirillo et al.
GYNECOLOGICAL ENDOCRINOLOGY (2020)
The polycystic ovary syndrome and gynecological cancer risk
Blazej Meczekalski et al.
GYNECOLOGICAL ENDOCRINOLOGY (2020)
Serum Androgens Are Independent Predictors of Insulin Clearance but Not of Insulin Secretion in Women With PCOS
Flavia Tosi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Emerging role of GIP and related gut hormones in fertility and PCOS
R. Charlotte Moffett et al.
PEPTIDES (2020)
Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes
Ralph A. DeFronzo et al.
DIABETES & VASCULAR DISEASE RESEARCH (2019)
Metabolic and hormonal effects of a combined Myo-inositol and D-chiro-inositol therapy on patients with polycystic ovary syndrome (PCOS)
Marcin Januszewski et al.
GINEKOLOGIA POLSKA (2019)
Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee
Enrico Carmina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study
Jacopo Troisi et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Breast cancer risk of hormonal contraception: Counselling considering new evidence
Lino Del Pup et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Molecular Mechanisms of Insulin Resistance in Polycystic Ovary Syndrome: Unraveling the Conundrum in Skeletal Muscle?
Nigel K. Stepto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both
Alessandro D. Genazzani et al.
GYNECOLOGICAL ENDOCRINOLOGY (2019)
Anti-Mullerian Hormone in PCOS: A Review Informing International Guidelines
Helena Teede et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)
Inositols' Importance in the Improvement of the Endocrine-Metabolic Profile in PCOS
Anna Wojciechowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Short-term effects of metformin and myo-inositol in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials
Fabio Facchinetti et al.
GYNECOLOGICAL ENDOCRINOLOGY (2019)
Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial
Maryam Shokrpour et al.
GYNECOLOGICAL ENDOCRINOLOGY (2019)
Treatment with d-chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome
Franca Fruzzetti et al.
GYNECOLOGICAL ENDOCRINOLOGY (2019)
The effect of myoinositol on ovarian blood flows in women with polycystic ovary syndrome
Ali Cenk Ozay et al.
GYNECOLOGICAL ENDOCRINOLOGY (2019)
Myo-inositol and D-chiro-inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model
Arturo Bevilacqua et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Lifestyle interventions and quality of life for women with polycystic ovary syndrome A systematic review and meta-analysis protocol
Romilson de Lima Nunes et al.
MEDICINE (2019)
Lifestyle changes in women with polycystic ovary syndrome
Siew S. Lim et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)
Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls
Selma Feldman Witchel et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients
M. Stracquadanio et al.
GYNECOLOGICAL ENDOCRINOLOGY (2018)
Ameliorative effect of myo-inositol on red blood cell alterations in polycystic ovary syndrome: in vitro study
Alessandra Andrisani et al.
GYNECOLOGICAL ENDOCRINOLOGY (2018)
Does myo-inositol oxygenase, the only enzyme to catalyze myo-inositol in vivo, play a role in the etiology of polycystic ovarian syndrome?
Cuma Mertoglu et al.
GYNECOLOGICAL ENDOCRINOLOGY (2018)
Combined oral contraceptives and/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis
Manuel Luque-Ramirez et al.
HUMAN REPRODUCTION UPDATE (2018)
Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients
A. D. Genazzani et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2018)
Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis
Mina Amiri et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2018)
The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review
Antoaneta Gateva et al.
GYNECOLOGICAL ENDOCRINOLOGY (2018)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Helena J. Teede et al.
HUMAN REPRODUCTION (2018)
Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
Seema Patel
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2018)
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
Hector F. Escobar-Morreale
NATURE REVIEWS ENDOCRINOLOGY (2018)
Effects of myo-inositol plus alphalactalbumin in myo-inositol-resistant PCOS women
Mario Montanino Oliva et al.
JOURNAL OF OVARIAN RESEARCH (2018)
Inositols in Insulin Signaling and Glucose Metabolism
Arturo Bevilacqua et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2018)
Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation
Carlo Bastianelli et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2018)
Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis
Liuting Zeng et al.
ENDOCRINE (2018)
D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress
Shuang-shuang Zhao et al.
ACTA PHARMACOLOGICA SINICA (2018)
Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial
Signe Frossing et al.
DIABETES OBESITY & METABOLISM (2018)
Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action
Simona De Cicco et al.
GYNECOLOGICAL ENDOCRINOLOGY (2017)
An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence
Lourdes Ibanez et al.
HORMONE RESEARCH IN PAEDIATRICS (2017)
Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes
Flavia Tosi et al.
HUMAN REPRODUCTION (2017)
Lifestyle and Behavioral Management of Polycystic Ovary Syndrome
Leah Brennan et al.
JOURNAL OF WOMENS HEALTH (2017)
Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta analysis comparing products containing cyproterone acetate with third generation progestins
Mina Amiri et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols
Maria A. Sortino et al.
FRONTIERS IN PHARMACOLOGY (2017)
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Lara C. Morley et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome
Susan Sam et al.
DIABETOLOGIA (2017)
The mechanisms of action of metformin
Graham Rena et al.
DIABETOLOGIA (2017)
Insulin and the polycystic ovary syndrome
Djuro Macut et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Comprehensive Assessment of the Hemostatic System in Polycystic Ovarian Syndrome
Genia F. Burchall et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2016)
Physiological role and clinical utility of inositols in polycystic ovary syndrome
Arturo Bevilacqua et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2016)
Effect of Serotonin Transporter 5-HTTLPR Polymorphism on Gastrointestinal Intolerance to Metformin: A GoDARTS Study
Tanja Dujic et al.
DIABETES CARE (2016)
Noncontraceptive use of oral combined hormonal contraceptives in polycystic ovary syndrome-risks versus benefits
Anuja Dokras
FERTILITY AND STERILITY (2016)
Criteria, prevalence, and phenotypes of polycystic ovary syndrome
Daria Lizneva et al.
FERTILITY AND STERILITY (2016)
Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies
Samantha Cassar et al.
HUMAN REPRODUCTION (2016)
Implications of Androgen Assay Accuracy in the Phenotyping of Women With Polycystic Ovary Syndrome
Flavia Tosi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Polycystic Ovary Syndrome
Christopher R. McCartney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Metformin or Oral Contraceptives for Adolescents With Polycystic Ovarian Syndrome: A Meta-analysis
Reem A. Al Khalifah et al.
PEDIATRICS (2016)
A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women
Elena Benelli et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2016)
Myo-Inositol in the Treatment of Teenagers Affected by PCOS
Lali Pkhaladze et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2016)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2
Neil F. Goodman et al.
ENDOCRINE PRACTICE (2015)
D-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS
Antonio Cianci et al.
GYNECOLOGICAL ENDOCRINOLOGY (2015)
Total Body Fat and Central Fat Mass Independently Predict Insulin Resistance but Not Hyperandrogenemia In Women With Polycystic Ovary Syndrome
Flavia Tosi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Approach to the Patient: Contraception in Women With Polycystic Ovary Syndrome
Bulent O. Yildiz
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study
Tanja Dujic et al.
DIABETES (2015)
Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls
Douglas Heimark et al.
ENDOCRINE JOURNAL (2014)
Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
Mojca Jensterle Sever et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Gerard Conway et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society
Didier Dewailly et al.
HUMAN REPRODUCTION UPDATE (2014)
The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis
Y. Zimmerman et al.
HUMAN REPRODUCTION UPDATE (2014)
Metformin induces a prompt decrease in LH-stimulated testosterone response in women with PCOS independent of its insulin-sensitizing effects
Dorothea Kurzthaler et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2014)
Potential role and therapeutic interests of myo-inositol in metabolic diseases
Marine L. Croze et al.
BIOCHIMIE (2013)
Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis
Steven T. Bird et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)
Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review
Jennifer M. Gierisch et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Metabolic and other effects of pioglitazone as an add-on therapy to metformin in the treatment of polycystic ovary syndrome (PCOS)
Georgios Valsamakis et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2013)
Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis
Mora Murri et al.
HUMAN REPRODUCTION UPDATE (2013)
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
Richard S. Legro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Referral Bias in Defining the Phenotype and Prevalence of Obesity in Polycystic Ovary Syndrome
Uche Ezeh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Divergences in Insulin Resistance Between the Different Phenotypes of the Polycystic Ovary Syndrome
Paolo Moghetti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Lifestyle Modification Programs in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
Juan Pablo Domecq et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Androgen Profiling by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) in Healthy Normal-Weight Ovulatory and Anovulatory Late Adolescent and Young Women
Flaminia Fanelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: A randomized study
D. Romualdi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2013)
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Russell A. Miller et al.
NATURE (2013)
Oral Contraceptive Pills as Primary Prevention for Ovarian Cancer A Systematic Review and Meta-analysis
Laura J. Havrilesky et al.
OBSTETRICS AND GYNECOLOGY (2013)
Metformin Inhibits Human Androgen Production by Regulating Steroidogenic Enzymes HSD3B2 and CYP17A1 and Complex I Activity of the Respiratory Chain
Andrea Hirsch et al.
ENDOCRINOLOGY (2012)
Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome
Sudhindra Mohan Bhattacharya et al.
FERTILITY AND STERILITY (2012)
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
Bart C. J. M. Fauser et al.
FERTILITY AND STERILITY (2012)
Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria
Bulent Okan Yildiz et al.
HUMAN REPRODUCTION (2012)
Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society
H. F. Escobar-Morreale et al.
HUMAN REPRODUCTION UPDATE (2012)
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
S. S. Lim et al.
HUMAN REPRODUCTION UPDATE (2012)
Hyperinsulinemia Amplifies GnRH Agonist Stimulated Ovarian Steroid Secretion in Women with Polycystic Ovary Syndrome
Flavia Tosi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia
Jacqueline A. Boyle et al.
MEDICAL JOURNAL OF AUSTRALIA (2012)
Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women
Flavia Tosi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Polycystic ovarian morphology in postmenarchal adolescents
Ethel Codner et al.
FERTILITY AND STERILITY (2011)
The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study
Gwinnett Ladson et al.
FERTILITY AND STERILITY (2011)
The D-chiro-inositol paradox in the ovary
Gianfranco Carlomagno et al.
FERTILITY AND STERILITY (2011)
Effect of ethinylestradiol/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study
Katerina K. Naka et al.
GYNECOLOGICAL ENDOCRINOLOGY (2011)
The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies
Ilana J. Halperin et al.
HUMAN REPRODUCTION (2011)
Drospirenone/Ethinyl Estradiol Versus Rosiglitazone Treatment in Overweight Adolescents with Polycystic Ovary Syndrome: Comparison of Metabolic, Hormonal, and Cardiovascular Risk Factors
Hala Tfayli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Hormonal Contraception and Thrombotic Risk: A Multidisciplinary Approach
Cameron C. Trenor et al.
PEDIATRICS (2011)
The diagnosis of polycystic ovary syndrome in adolescents
Enrico Carmina et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
Hormonal contraception and risk of endometrial cancer: a systematic review
Alfred O. Mueck et al.
ENDOCRINE-RELATED CANCER (2010)
Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
Evanthia Diamanti-Kandarakis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin
Miranda Harris-Glocker et al.
FERTILITY AND STERILITY (2010)
Hormonal contraception and risk of cancer
D. Cibula et al.
HUMAN REPRODUCTION UPDATE (2010)
Metabolic and Hormonal Changes Induced by Pioglitazone in Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Clinical Trial
Vanita R. Aroda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial
Alan Garber et al.
LANCET (2009)
Insulin sensitizers for the treatment of hirsutism: A systematic review and metaanalyses of randomized controlled trials
Mihaela Cosma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome
Karen Elkind-Hirsch et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls
V. Beral et al.
LANCET (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome
Pilar Vigil et al.
HUMAN REPRODUCTION (2007)
Ca2+/calmodulin-dependent protein kinase kinase is involved in AMP-activated protein kinase activation by α-lipoic acid in C2C12 myotubes
Qingwu W. Shen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism
Cem Batukan et al.
GYNECOLOGICAL ENDOCRINOLOGY (2007)
Lifestyle choices, diet, and insulin sensitizers in polycystic ovary syndrome
R. J. Norman et al.
ENDOCRINE (2006)
Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study
K. Rautio et al.
HUMAN REPRODUCTION (2006)
Treatment of hirsutism and acne in hyperandrogenism
Paolo Moghetti et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome
G Mastorakos et al.
FERTILITY AND STERILITY (2006)
Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance
AD Coviello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance
A Lemay et al.
HUMAN REPRODUCTION (2006)
Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome
NA Cataldo et al.
HUMAN REPRODUCTION (2006)
α-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle
WJ Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
BCJM Fauser et al.
HUMAN REPRODUCTION (2004)
Metformin has direct effects on human ovarian steroidogenesis
R Mansfield et al.
FERTILITY AND STERILITY (2003)
Metformin: An update
D Kirpichnikov et al.
ANNALS OF INTERNAL MEDICINE (2002)
Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives
G Mastorakos et al.
FERTILITY AND STERILITY (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Metformin directly inhibits androgen production in human thecal cells
GR Attia et al.
FERTILITY AND STERILITY (2001)
The antihyperglycemic drug α-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation -: Potential role of p38 mitogen-activated protein kinase in GLUT4 activation
D Konrad et al.
DIABETES (2001)
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial
R Azziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome
VD Lewy et al.
JOURNAL OF PEDIATRICS (2001)
分享论文
